Investment area

Growth Investments

Bioindustrial Investments


North America

Date of investment

November 2019

bioMASON, Inc. is a unique biomaterials startup whose technology provides a better solution for reducing the CO2 emissions generated by global masonry manufacturing.

Visit site


Anders Bendsen Spohr

Senior Partner, Head of Bioindustrial Investments

Departments: Bioindustrial Investments, Life Sciences Operating Committee

Anders joined Novo Holdings A/S in 2017.
Anders is Sr Partner and Head of the Bioindustrial investments team.

Prior to joining Novo Holdings, Anders was employed as VP in Xellia Pharmaceuticals heading up the Global Product Supply. Other previous employments include EVP, Global Product Supply at Leo Pharma A/S and VP Global Supply Chain at Novozymes A/S.

Anders holds a PhD in Biotechnology and a MSc in Chemical Engineering from Technical University of Denmark as well as a graduate diploma in Business Administration (International Business) from Copenhagen Business School.